Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Philip Wastall | Researchclopedia

Back to researchers

Philip Wastall

Bristol-Myers Squibb (United States)

10

Works

1,598

Citations

7

h-index

6

i10-index

Research Topics

Pharmacogenetics and Drug Metabolism Hepatitis C virus research Atrial Fibrillation Management and Outcomes

Affiliations

Pfizer (United Kingdom)1996–2002

Bristol-Myers Squibb (United States)2014–2016

Bristol-Myers Squibb (Sweden)2015–2015

Top Works

The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.

R. Scott Obach,James G. Baxter,et al.

1997638 citations

Computational Drug Discovery Methods

Pharmacological Effects and Toxicity Studies

The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data

R. Scott Obach,James G. Baxter,et al.

1997577 citations

Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils

Todd G. Kirchgessner,Paul G. Sleph,et al.

2016158 citations

Comparative human pharmacokinetics and metabolism of single‐dose oral and intravenous sildenafil

Gary J. Muirhead,David J. Rance,et al.

2002119 citations

A randomised assessment of the pharmacokinetic, pharmacodynamic and safety interaction between apixaban and enoxaparin in healthy subjects

Jessie J. Wang,Yan Song,et al.

201254 citations

Assessment of Drug-Drug Interactions between Daclatasvir and Methadone or Buprenorphine-Naloxone

Τushar Garimella,R. Wang,et al.

201534 citations

Evaluation of drug‐drug interaction between daclatasvir and methadone or buprenorphine/naloxone

Τushar Garimella,Reena Wang,et al.

20148 citations

Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man

S. G. Jezequel,S. Uden,et al.

19967 citations

Safety, pharmacokinetics, and pharmacodynamics of PD 0348292, an oral, direct factor Xa inhibitor, after single and multiple dosings in healthy subjects

Dawei Xuan,Scott McBride,et al.

20153 citations